M Voss
Impact in
Papers in
- Oncology 3
- CAR-T cell therapy research 1
- Cancer Immunotherapy and Biomarkers 1
-
- Immunotherapy and Immune Responses 2
- Phagocytosis and Immune Regulation 1
- Co-authors
- Uwe M. Martens (1 shared paper)Stefan Zimmermann (1 shared paper)S Kaiser (1 shared paper)Ursula Kapp (1 shared paper)Cornelius F. Waller (1 shared paper)Holger Kalthoff (3 shared papers)Hendrik Ungefroren (2 shared papers)Christian Roeder (1 shared paper)
- Journals
- Gut (2 papers)Leukemia (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)PubMed (2 papers)
In The Last Decade
M Voss
6 papers receiving 883 citations
Peers
Comparison fields: 5 of 67
- Oncology 556
- Genetics 160
- Epidemiology 347
- Neurology 134
- Gastroenterology 37
Countries citing papers authored by M Voss
This map shows the geographic impact of M Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Voss more than expected).
Fields of papers citing papers by M Voss
This network shows the impact of papers produced by M Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Voss. The network helps show where M Voss may publish in the future.
Co-authors
The 22 scholars most cited alongside M Voss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 276 | |
| 2 | 2003 | 205 | |
| 3 | 1998 | 201 | |
| 4 | Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. | 1998 | 189 |
| 5 | 2002 | 36 | |
| 6 | [CD95 resistance and Fas ligand synthesis as mechanism of defense by immunocompetent cells in pancreatic tumors]. | 1998 | 2 |
About M Voss
M Voss is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Epidemiology, having authored 6 papers that have together received 909 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Phagocytosis and Immune Regulation (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Oncology (556 citations), Genetics (160 citations), Epidemiology (347 citations), Neurology (134 citations) and Gastroenterology (37 citations). M Voss has collaborated with scholars based in Germany and France. Frequent co-authors include Uwe M. Martens, Stefan Zimmermann, S Kaiser, Ursula Kapp, Cornelius F. Waller, Holger Kalthoff, Hendrik Ungefroren, Christian Roeder, Doris Henne‐Bruns and B. Kremer. Their work appears in journals such as Gut, Leukemia, Journal of Cancer Research and Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.